RhumbLine Advisers’s CARGO Therapeutics CRGX Stock Holding History

RhumbLine Advisers’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-49,795	Closed	-$205K	–	4138
2025 Q2	$205K	Buy	49,795 +2,392	+5%	+$10.2K	﹤0.01%	3216
2025 Q1	$193K	Sell	47,403 -2,676	-5%	-$17.9K	﹤0.01%	3117
2024 Q4	$722K	Buy	50,079 +2,291	+5%	+$41.6K	﹤0.01%	2432
2024 Q3	$882K	Buy	47,788 +17,149	+56%	+$307K	﹤0.01%	2332
2024 Q2	$503K	Buy	30,639 +3,765	+14%	+$71.6K	﹤0.01%	2679
2024 Q1	$600K	Buy	+26,874	New	+$639K	﹤0.01%	2551

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RhumbLine Advisers's CRGX Position: Q3 2025 in Review

RhumbLine Advisers sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 49,795 shares — an estimated $205K sold.

RhumbLine Advisers first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $882K in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

RhumbLine Advisers reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
RhumbLine Advisers sold 49,795 CARGO Therapeutics shares in Q3 2025, an estimated $205K.
RhumbLine Advisers first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
RhumbLine Advisers's CARGO Therapeutics position peaked at $882K in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.